Effect of in Vivo GnRH Agonist and GnRH Antagonist on HCG and Insulin-stimulated Progesterone Production by Human Granulosa-lutein Cells in Vitro
Overview
Reproductive Medicine
Authors
Affiliations
Purpose: To investigate hCG and insulin-stimulated progesterone (P) production by human granulosa-lutein cells (hGLC) in vitro.
Methods: hGLCs were isolated from patients undergoing IVF-ET cycles in which GnRH agonist or GnRH antagonist was used to prevent a midcycle gonadotropin surge. The cells were cultured for 3 days, and then treated with hCG 0.5, 1, and 10 IU/I, and insulin 0.01, 0.1, and 1 microM in serum free conditions. In vitro P production was measured by enzyme immunoassay.
Results: hCG stimulated P production by hGLCs from cycles in which GnRH antagonist was used, but a blunted response was seen in GnRH-agonist treated cycles. Insulin-stimulated P production was similar in cells from cycles in which GnRH-agonist or GnRH-antagonist treatment was used.
Conclusions: Because insulin and hCG may share common pathways beyond the level of receptor activation, we hypothesize that GnRH agonist, but not GnRH antagonist, may affect the expression and/or activation of LH receptors in the hGLCs.
Mitwally M, Casper R, Diamond M Reprod Biol Endocrinol. 2005; 3:54.
PMID: 16202169 PMC: 1266397. DOI: 10.1186/1477-7827-3-54.